Sattrix Information Security Regulatory Approval

New Order Win

Sattrix Information Security Bags ₹2.43 Cr Order

Sattrix Information Security received cybersecurity work orders aggregating to ₹2.43 Crore in October 2026. Orders span multiple industries for products, licensing, and support services.

Value

₹2.43 Cr

Board Meeting Date

Sattrix Information Security Board Meeting Date

Sattrix Information Security Ltd scheduled a board meeting for 04 November 2026 to consider H1 FY27 financial results. Trading window remains closed until 48 hours post-results.

Other Announcement

Sattrix Information Security Other Announcement

Sattrix Information Security Ltd has filed its quarterly shareholding pattern as of September 30, 2026. This disclosure provides details on the company's shareholding structure.

Other Announcement

Sattrix Information Security Other Announcement

Sattrix withdrew a press release about September 2026 purchase orders, citing inadvertent filing due to internal oversight. No new business information is conveyed.

Business Update

Sattrix Information Security Business Update

Sattrix Information Security Ltd reported purchase orders worth Rs.0.48 Crore received in September 2026. The orders cover cybersecurity products, software licensing and support services from unnamed customers.

Value

₹0.48 Cr

Price Movement Clarification

Sattrix Information Security Price Movement Clarification

Sattrix Information Security Limited clarified that recent share price movements are market-driven and speculative in nature, with no undisclosed material information affecting the security.

Regulatory ApprovalDr. Reddy's Laboratories Ltd DRREDDYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Dr. Reddy's Laboratories Regulatory Approval

Dr. Reddy's Laboratories received marketing authorization from Brazil's ANVISA for its generic semaglutide injection. The approval targets Brazil's diabetes market, estimated at approximately USD 244.6 million.

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for its generic Olopatadine Hydrochloride Ophthalmic Solution 0.7% ANDA. The product's US market is estimated at $20 million, per IQVIA.

Regulatory ApprovalEmmbi Industries Ltd EMMBIAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Emmbi Industries Regulatory Approval

SEBI exempted the Makrand and Rinku Appalwar business trusts from SAST takeover rules for an internal family share transfer. Control and promoter shareholding remain unchanged.

Regulatory ApprovalBliss GVS Pharma Ltd BLISSGVSAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Bliss GVS Pharma Regulatory Approval

Bliss GVS Pharma's UK subsidiary Asterisk Lifesciences received MHRA marketing authorisation for Mesalazine 1g Suppositories. The approval lets the subsidiary market the product in the UK.

Regulatory ApprovalJohn Cockerill India Ltd COCKERILLAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

John Cockerill India Regulatory Approval

John Cockerill India received Reserve Bank of India approval for acquiring shares of John Cockerill Metals International SA. This allows the company to proceed with the share-swap acquisition.

Regulatory ApprovalGland Pharma Ltd GLANDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Gland Pharma Regulatory Approval

Gland Pharma received USFDA approval for Methylprednisolone Acetate Injectable Suspension USP in multiple vial formats. The product is bioequivalent to Pfizer's Depo-Medrol in a ~$214M US market.